Post-anastomotic venous stenosis after Optiflow deployment: An unexpected outcome

Arteriovenous fistula failure represents a major cause of hospitalization and a significant economic burden for end-stage renal disease patients on hemodialysis. The Optiflow (Bioconnect Systems Inc., Ambler, PA) is a new device developed to improve arteriovenous fistula outcomes and decrease failur...

Full description

Bibliographic Details
Main Authors: Ziad Al Adas, George Haddad, Bhavin C Patel, Lalathaksha Kumbar, Baha Al-Abid, Praveen Balraj, Loay S Kabbani
Format: Article
Language:English
Published: SAGE Publishing 2019-05-01
Series:SAGE Open Medical Case Reports
Online Access:https://doi.org/10.1177/2050313X19851002
id doaj-e08709b650d245dcb9b7935214986bf4
record_format Article
spelling doaj-e08709b650d245dcb9b7935214986bf42020-11-25T02:34:26ZengSAGE PublishingSAGE Open Medical Case Reports2050-313X2019-05-01710.1177/2050313X19851002Post-anastomotic venous stenosis after Optiflow deployment: An unexpected outcomeZiad Al Adas0George Haddad1Bhavin C Patel2Lalathaksha Kumbar3Baha Al-Abid4Praveen Balraj5Loay S Kabbani6Department of Vascular Surgery, Henry Ford Hospital, Detroit, MI, USADepartment of Vascular Surgery, Henry Ford Hospital, Detroit, MI, USADepartment of Nephrology, Henry Ford Hospital, Detroit, MI, USADepartment of Nephrology, Henry Ford Hospital, Detroit, MI, USADepartment of Nephrology, Henry Ford Hospital, Detroit, MI, USADepartment of Vascular Surgery, Henry Ford Hospital, Detroit, MI, USADepartment of Vascular Surgery, Henry Ford Hospital, Detroit, MI, USAArteriovenous fistula failure represents a major cause of hospitalization and a significant economic burden for end-stage renal disease patients on hemodialysis. The Optiflow (Bioconnect Systems Inc., Ambler, PA) is a new device developed to improve arteriovenous fistula outcomes and decrease failure rates by reducing the risk of stenosis and improving maturation rates. This case report describes a 50-year-old male with hypertensive nephropathy on dialysis who had multiple arteriovenous fistula failures in the past. He was scheduled to undergo brachiocephalic fistula construction using the Optiflow device. After 8 months of use, the new fistula developed a peri-anastomotic venous stenosis, just distal to the Optiflow device. To our knowledge, this is the first time such a complication has been reported.https://doi.org/10.1177/2050313X19851002
collection DOAJ
language English
format Article
sources DOAJ
author Ziad Al Adas
George Haddad
Bhavin C Patel
Lalathaksha Kumbar
Baha Al-Abid
Praveen Balraj
Loay S Kabbani
spellingShingle Ziad Al Adas
George Haddad
Bhavin C Patel
Lalathaksha Kumbar
Baha Al-Abid
Praveen Balraj
Loay S Kabbani
Post-anastomotic venous stenosis after Optiflow deployment: An unexpected outcome
SAGE Open Medical Case Reports
author_facet Ziad Al Adas
George Haddad
Bhavin C Patel
Lalathaksha Kumbar
Baha Al-Abid
Praveen Balraj
Loay S Kabbani
author_sort Ziad Al Adas
title Post-anastomotic venous stenosis after Optiflow deployment: An unexpected outcome
title_short Post-anastomotic venous stenosis after Optiflow deployment: An unexpected outcome
title_full Post-anastomotic venous stenosis after Optiflow deployment: An unexpected outcome
title_fullStr Post-anastomotic venous stenosis after Optiflow deployment: An unexpected outcome
title_full_unstemmed Post-anastomotic venous stenosis after Optiflow deployment: An unexpected outcome
title_sort post-anastomotic venous stenosis after optiflow deployment: an unexpected outcome
publisher SAGE Publishing
series SAGE Open Medical Case Reports
issn 2050-313X
publishDate 2019-05-01
description Arteriovenous fistula failure represents a major cause of hospitalization and a significant economic burden for end-stage renal disease patients on hemodialysis. The Optiflow (Bioconnect Systems Inc., Ambler, PA) is a new device developed to improve arteriovenous fistula outcomes and decrease failure rates by reducing the risk of stenosis and improving maturation rates. This case report describes a 50-year-old male with hypertensive nephropathy on dialysis who had multiple arteriovenous fistula failures in the past. He was scheduled to undergo brachiocephalic fistula construction using the Optiflow device. After 8 months of use, the new fistula developed a peri-anastomotic venous stenosis, just distal to the Optiflow device. To our knowledge, this is the first time such a complication has been reported.
url https://doi.org/10.1177/2050313X19851002
work_keys_str_mv AT ziadaladas postanastomoticvenousstenosisafteroptiflowdeploymentanunexpectedoutcome
AT georgehaddad postanastomoticvenousstenosisafteroptiflowdeploymentanunexpectedoutcome
AT bhavincpatel postanastomoticvenousstenosisafteroptiflowdeploymentanunexpectedoutcome
AT lalathakshakumbar postanastomoticvenousstenosisafteroptiflowdeploymentanunexpectedoutcome
AT bahaalabid postanastomoticvenousstenosisafteroptiflowdeploymentanunexpectedoutcome
AT praveenbalraj postanastomoticvenousstenosisafteroptiflowdeploymentanunexpectedoutcome
AT loayskabbani postanastomoticvenousstenosisafteroptiflowdeploymentanunexpectedoutcome
_version_ 1724808933270355968